Business Wire6d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
News Medical on MSN4d
Low vitamin D in first trimester linked to higher preterm birth risk and reduced fetal length
Maternal vitamin D status in early pregnancy is crucial for fetal growth and may reduce the risk of preterm birth, according ...
The American Journal of Managed Care1h
Changes in Tumor Size Track Advanced RCC Outcomes, Analyses From CLEAR Show
Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...
Endocrinology Advisor5d
Susvimo Approval Expanded to Include Diabetic Macular Edema
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
ophthalmologytimes4d
Study finds faricimab effective for nAMD patients unresponsive to other anti-VEGF treatments
This research team evaluated the effectiveness of switching patients to faricimab treatment by assessing their outcomes after ...
Pharmabiz5d
Roche’s Susvimo receives US FDA approval for the treatment of diabetic macular edema
Roche’s Susvimo receives US FDA approval for the treatment of diabetic macular edema: Basel Thursday, February 6, 2025, 11:00 Hrs [IST] Roche announced that the US Food and Drug ...
GlobalData on MSN4d
FDA fast tracks Bracco’s BR55 for Crohn’s disease bowel inflammation detection
The company is currently preparing for Phase III trials to further assess the efficacy and safety of the agent in identifying ...
Le Lézard1d
Accord BioPharma Strengthens Pipeline Through Exclusive U.S. Licensing Agreement with Bio-Thera for BAT2506, a Proposed Golimumab Biosimilar
Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd. ("Intas Pharmaceuticals"), focused on the development ...
Pharm Exec6d
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...
Short Interest in Compass Therapeutics, Inc. (NASDAQ:CMPX) Rises By 5.2%
Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 2,210,000 shares, ...
Bio-Thera Solutions Announces Regulatory Filing Acceptance For BAT2506, A Proposed Biosimilar To Simponi®, In The European Union
The European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for BAT2506 as a biosimilar to reference p ...
The American Journal of Managed Care4d
5 Things to Know During AMD Awareness Month
Signs and symptoms of age-related macular degeneration (AMD) are important to spot to prevent further deterioration of sight.